| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/09/2005 | CN1188412C Process for preparing crystalline form 1 of cabergoline |
| 02/09/2005 | CN1188405C New Morpholinobenzamide salts |
| 02/09/2005 | CN1188402C Piperazinone derivs. and their uses |
| 02/09/2005 | CN1188172C G-CSF conjugates |
| 02/09/2005 | CN1188148C Process for preparing staltic-antagic medicine to treat trauma |
| 02/09/2005 | CN1188136C Buffered composition for dialysis |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852818 Molecularly imprinted polymers produced by template polymerization |
| 02/08/2005 | US6852749 Pyrazolidinol compounds |
| 02/08/2005 | US6852740 Treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I Mitogen-activated protein kinases (MAP) is a family of proline- directed serine/threonine kinases that activate their |
| 02/08/2005 | US6852732 A tetrahydropyridino or piperidino heterocyclic derivative represented by the formula (I): has a high affinity for CRF receptors and is effective against diseases in which CRF is considered to be involved. (Corticotropin releasing factor |
| 02/08/2005 | US6852727 Inhibitors of Janus protein tyrosine kinases (Jak), and as such are useful as immunosuppressants, and in the treatment of diseases including asthma, allergies, autoimmune diseases. |
| 02/08/2005 | US6852726 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852707 Using xylobiose or xylooligosaccharide containing xylobiose as a main ingredient in place of lactulose, there is provided a blood ammonia lowering agent, a therapeutic agent of hyperammonemia or a therapeutic agent of hepatic |
| 02/08/2005 | US6852537 Transgenic circulating endothelial cells |
| 02/08/2005 | US6852533 For making vectors for gene therapy |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852230 Method for the manufacture of compositions containing low concentrations of salts |
| 02/08/2005 | CA2180103C Gene encoding adseverin |
| 02/03/2005 | WO2005010051A2 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures |
| 02/03/2005 | WO2005009971A1 Quinolone derivative or salt thereof |
| 02/03/2005 | WO2005009452A1 A composition for decreasing the risk of long-haul traveller’s syndrome comprising a mixture of pycnogenol and standardized giger root extract |
| 02/03/2005 | WO2005009445A1 A1 adenosine receptor antagonists |
| 02/03/2005 | WO2005009428A2 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 02/03/2005 | WO2004110469A3 Formulations comprising factor viia and a factor vii related polypeptide |
| 02/03/2005 | WO2004083250A9 Construct comprising recognition domain of antibody against von willebrand factor-specific cleaving enzyme |
| 02/03/2005 | WO2004070018A3 Vegf-b and pdgf modulation of stem cells |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027009 New derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/03/2005 | US20050026967 Inhibitors of c-jun N terminal kinases (JNK) and other protein kinases |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/03/2005 | US20050026928 Chemical compounds |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer |
| 02/03/2005 | US20050026840 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics |
| 02/03/2005 | US20050026824 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 02/03/2005 | US20050026816 modified via polyoxyethylene glycol; improved stability to autooxidation; blood substitutes |
| 02/03/2005 | US20050026220 Isolation and mobilization of stem cells expressing vegfr-1 |
| 02/03/2005 | US20050025806 A silicone support of methylvinylsiloxane polymer including a fumed silca reinforcement filler; growth and/or reproduction-associated drug, derivative or analogue and carrier; each implant of insufficient size and/or payload for the predetermined threshold blood level of indicated drug; high-speed |
| 02/03/2005 | US20050025757 Oxygen carrier system, artificial oxygen carrier, and reducing agent |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | CA2536644A1 Antibodies and uses thereof |
| 02/03/2005 | CA2533555A1 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures |
| 02/03/2005 | CA2533402A1 A1 adenosine receptor antagonists |
| 02/03/2005 | CA2532608A1 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 02/03/2005 | CA2530352A1 Quinolone derivative or salt thereof |
| 02/02/2005 | EP1502595A1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof |
| 02/02/2005 | EP1502594A1 A health care composition for decreasing the risk of thrombosis including a mixture of proanthocyanidins and sesquiterpenes |
| 02/02/2005 | EP1501948A1 A dna enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/02/2005 | EP1501852A2 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 02/02/2005 | EP1501835A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501826A2 Substituted indoles as alpha-1 agonists |
| 02/02/2005 | EP1501819A1 Estrogen receptor modulators |
| 02/02/2005 | EP1501814A1 Semicarbazide derivatives for combating thromboembolic diseases |
| 02/02/2005 | EP1501813A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/02/2005 | EP1501808A1 Tachykinin receptor antagonists |
| 02/02/2005 | EP1501566A1 Medical products comprising a haemocompatible coating, production and use thereof |
| 02/02/2005 | EP1501565A1 Compounds and method for coating surfaces in a haemocompatible manner |
| 02/02/2005 | EP1501524A2 Internal image antibodies for optical imaging and therapy |
| 02/02/2005 | EP1501514A2 Protein kinase modulators and methods of use |
| 02/02/2005 | EP1501512A2 4-azasteroid derivatives as androgen receptor modulators |
| 02/02/2005 | EP1501495A1 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori |
| 02/02/2005 | EP1501493A1 Use of epa and dha in secondary prevention |
| 02/02/2005 | EP1501482A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 02/02/2005 | EP1440161A4 7118, a human arginine n-methyltransferase family member and uses therefor |
| 02/02/2005 | EP1349589B1 A device for dispensing at least two mutually reactive components |
| 02/02/2005 | CN1575341A Method for preparing heparin from mast cell cultures |
| 02/02/2005 | CN1575302A Human tissue factor antibodies |
| 02/02/2005 | CN1575289A 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575191A Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors |
| 02/02/2005 | CN1575190A Bag system for the cryopreservation of body fluids |
| 02/02/2005 | CN1575189A Stent, process for production thereof and its use for treating for restenosen and/or trombozen |
| 02/02/2005 | CN1575182A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/02/2005 | CN1575179A Combination product comprising melagatran and dexamethasone |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575174A Pharmaceutically active isoindoline derivatives |
| 02/02/2005 | CN1572882A Benzamidine derivatives |
| 02/02/2005 | CN1572320A Method for erythropoietin administration using pharmacokinetic and pharmacodynamic modeling |
| 02/02/2005 | CN1572313A Chinese patent medicine for treating vaginal bleeding after medicinal abortion operation and its preparation method |
| 02/02/2005 | CN1572153A Biological process for the production of a food product comprising heme-iron and food product obtained with said process |
| 02/02/2005 | CN1187447C MPL ligand analogs |
| 02/02/2005 | CN1187364C 类固醇衍生物 Steroid derivatives |
| 02/02/2005 | CN1187360C Phosphonic acid derivatives having carboxypeptidase B inhibitory activity |
| 02/02/2005 | CN1187354C Adenosine receptor antagonists and methods of making and using the same |
| 02/02/2005 | CN1187351C Bispidine compounds, their use and preparation method, intermediate and pharmaceutical compositions containing same |
| 02/02/2005 | CN1187330C Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187073C Medicine composition for treating condyloma acuminatum and its prepation method |
| 02/02/2005 | CN1187062C Chinese medicine preparation for curing hematopathy |
| 02/02/2005 | CN1187058C Stem cell medicine for repairing damage of central nerve and its preparing process |
| 02/02/2005 | CN1187051C Xanthine-based compound for preparation of medicine for enhancing insulin action |
| 02/01/2005 | US6849662 Therapeutic uses for nitric oxide inhibitors |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849646 Chromenone and chromanone derivatives as integrin inhibitors |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |